Genitourinary Radiology: Page 22

PSMA-PET agent could aid prostate cancer patients

By AuntMinnie.com staff writers

Japanese and German researchers are reporting early success with a PET imaging agent that could both diagnose and treat patents with prostate cancer, according to a preclinical study published in the November issue of the Journal of Nuclear Medicine.

November 17, 2019

AR, 3D printing may improve prostatectomy outcomes

By Abraham Kim

Tuesday, December 3 | 3:30 p.m.-3:40 p.m. | SSJ13-04 | Room S501ABCAugmented reality (AR) and 3D-printed models based on the MRI scans of patients with prostate cancer may help reduce operating times, blood loss, and positive surgical margins for prostatectomy, researchers will report in this Tuesday session.

November 11, 2019

Testicular volume helps diagnose torsion

By Kate Madden Yee

Thursday, December 5 | 11:10 a.m.-11:20 a.m. | SSQ17-05 | S105ABIn this session, researchers will describe how using ultrasound to evaluate pediatric testicular volume can help diagnose torsion.

November 10, 2019

DECT more cost-effective than CT, MRI for kidney lesions

By Abraham Kim

Sunday, December 1 | 11:35 a.m.-11:45 a.m. | SSA11-06 | Room N230BDual-energy CT (DECT) may be more cost-effective than conventional CT or MRI for evaluating incidentally detected renal lesions, based on simulations from an analytical model that serve as the subject of this study to be presented on Sunday.

November 6, 2019

VI-RADS complements mpMRI for bladder cancer

By Wayne Forrest

Friday, December 6 | 11:50 a.m.-12:00 p.m. | SST04-09 | Room E350Adding the Vesical Imaging-Reporting and Data System (VI-RADS) to multiparametric MRI (mpMRI) scans could be a boon for evaluating bladder cancer.

November 5, 2019

Deep-learning model could triage renal ultrasound exams

By Erik L. Ridley

Thursday, December 5 | 11:10 a.m.-11:20 a.m. | SSQ10-05 | Room E352A deep-learning algorithm can detect abnormalities on renal ultrasound exams, potentially enabling triage of these cases for radiologists, according to this scientific presentation.

November 3, 2019

AI enhances multiparametric MRI reads

By Erik L. Ridley

Wednesday, December 4 | 3:20 p.m.-3:30 p.m. | SSM12-03 | Room N229Artificial intelligence (AI) can improve the sensitivity of radiologists for detecting intraprostatic lesions on multiparametric MRI, according to a multinational team of researchers.

November 3, 2019

MRI restaging for recurrent prostate cancer has its flaws

By Wayne Forrest

MRI has a tendency to either overstage or understage disease in patients with recurrent prostate cancer after treatment, primarily due to the misinterpretation of fibrosis, according to a study published in the November issue of the American Journal of Roentgenology.

October 27, 2019

Automated bone scan software proves worth with radium-223

By Wayne Forrest

An automated bone scan algorithm has shown its value in determining the response to radium-223 (Ra-223) treatment for patients with metastatic castration-resistant prostate cancer, according to a study published online October 4 in the Journal of Nuclear Medicine.

October 9, 2019

GE, Theragnostics partner on PSMA agent

By AuntMinnie.com staff writers

GE Healthcare and Theragnostics have signed a global partnership to develop a new prostate-specific membrane antigen (PSMA) PET/CT imaging agent.

October 8, 2019

Prostate cancer patients prefer mpMRI over biopsy

By Wayne Forrest

Low-risk prostate cancer patients who underwent multiparametric MRI (mpMRI) for active surveillance of the disease felt better about their experience than those who underwent transrectal biopsy, according to a study in the October issue of the Journal of the American College of Radiology.

October 3, 2019

Ga-68 PSMA-11 PET interpretation criteria need work

By Wayne Forrest

Interpretation criteria for gallium-68 (Ga-68) prostate-specific membrane antigen-11 (PSMA-11) PET with CT or MRI for prostate cancer can bolster interreader agreement, but some performance issues remain, according to a study published online September 27 in the Journal of Nuclear Medicine.

October 1, 2019

Previous Page

Page 22 of 93

Next Page